Chloroquine and hydroxychloroquine provoke arrhythmias at concentrations higher than those clinically used to treat COVID‐19: A simulation study

ABSTRACT: The risk of fatal arrhythmias is the major concern for using chloroquine (CQ) or hydroxychloroquine (HCQ) to treat coronavirus disease 2019 (COVID‐19), but the reported number of life‐threatening arrhythmic events or deaths is relatively small. The objective of this study was to assess the...

Descripción completa

Detalles Bibliográficos
Autores principales: Okada, Jun‐ichi, Yoshinaga, Takashi, Washio, Takumi, Sawada, Kohei, Sugiura, Seiryo, Hisada, Toshiaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8212750/
https://www.ncbi.nlm.nih.gov/pubmed/33404133
http://dx.doi.org/10.1111/cts.12976

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8212750/
https://www.ncbi.nlm.nih.gov/pubmed/33404133
http://dx.doi.org/10.1111/cts.12976

Ejemplares similares